Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
ULBI

ULBI - Ultralife Corp Stock Price, Fair Value and News

11.24USD-0.41 (-3.52%)Market Closed

Market Summary

ULBI
USD11.24-0.41
Market Closed
-3.52%

ULBI Stock Price

View Fullscreen

ULBI RSI Chart

ULBI Valuation

Market Cap

185.1M

Price/Earnings (Trailing)

17.74

Price/Sales (Trailing)

1.1

EV/EBITDA

10.91

Price/Free Cashflow

235.48

ULBI Price/Sales (Trailing)

ULBI Profitability

Operating Margin

25.63%

EBT Margin

7.82%

Return on Equity

8.1%

Return on Assets

5.78%

Free Cashflow Yield

0.42%

ULBI Fundamentals

ULBI Revenue

Revenue (TTM)

168.7M

Rev. Growth (Yr)

31.37%

Rev. Growth (Qtr)

-5.88%

ULBI Earnings

Earnings (TTM)

10.4M

Earnings Growth (Yr)

935.55%

Earnings Growth (Qtr)

0.63%

Breaking Down ULBI Revenue

Last 7 days

-8.8%

Last 30 days

28.0%

Last 90 days

22.2%

Trailing 12 Months

155.5%

How does ULBI drawdown profile look like?

ULBI Financial Health

Current Ratio

4.03

Debt/Equity

0.18

Debt/Cashflow

0.14

ULBI Investor Care

Shares Dilution (1Y)

2.05%

Diluted EPS (TTM)

0.34

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024168.7M000
2023133.4M143.9M150.2M158.6M
2022102.7M108.0M119.5M131.8M
2021107.9M106.1M103.5M98.3M
2020113.7M112.9M109.8M107.7M
201983.0M89.5M96.7M106.8M
201886.6M89.5M88.8M87.2M
201783.7M83.2M84.6M85.5M
201678.1M79.5M80.1M82.5M
201570.4M74.1M77.1M76.4M
201473.1M71.0M66.7M66.5M
201395.2M93.7M87.9M78.8M
2012135.3M110.9M101.9M101.7M
2011158.3M167.7M152.1M135.7M
20100158.5M162.6M166.8M
2009000154.3M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Ultralife Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 17, 2024
fain philip a
acquired
40,974
5.7075
7,179
cfo and treasurer
Mar 13, 2024
manna michael edward
bought
8,600
8.6
1,000
president and ceo
Dec 27, 2023
manna michael edward
acquired
26,841
5.3057
5,059
president and ceo
Dec 08, 2023
whitmore bradford t
bought
50,339
7.1913
7,000
-
Dec 06, 2023
whitmore bradford t
bought
60,604
6.8271
8,877
-
Nov 29, 2023
whitmore bradford t
bought
78,841
7.3409
10,740
-
Nov 28, 2023
whitmore bradford t
bought
79,027
7.0813
11,160
-
Nov 27, 2023
whitmore bradford t
bought
22,782
7.1196
3,200
-
Nov 10, 2023
manna michael edward
bought
3,715
7.43
500
president and ceo
Nov 01, 2023
whitmore bradford t
bought
8,266
7.5146
1,100
-

1–10 of 50

Which funds bought or sold ULBI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 16, 2024
JANE STREET GROUP, LLC
added
139
213,075
314,870
-%
May 15, 2024
MARSHALL WACE, LLP
reduced
-1.72
82,011
386,292
-%
May 15, 2024
MORGAN STANLEY
reduced
-60.77
-41,040
42,164
-%
May 15, 2024
STATE STREET CORP
reduced
-3.02
85,728
424,818
-%
May 15, 2024
HSBC HOLDINGS PLC
new
-
93,527
93,527
-%
May 15, 2024
BANK OF AMERICA CORP /DE/
added
54,650
28,900
28,941
-%
May 15, 2024
BARCLAYS PLC
reduced
-54.62
-69,000
98,000
-%
May 15, 2024
Visionary Wealth Advisors
added
1.83
2,328,570
9,709,490
0.66%
May 15, 2024
Squarepoint Ops LLC
new
-
122,441
122,441
-%
May 15, 2024
Cubist Systematic Strategies, LLC
added
7.36
42,167
151,171
-%

1–10 of 47

Are Funds Buying or Selling ULBI?

Are funds buying ULBI calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own ULBI
No. of Funds

Unveiling Ultralife Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
visionary wealth advisors
6.62%
1,082,246
SC 13G
Feb 09, 2024
dimensional fund advisors lp
5.7%
931,030
SC 13G/A
Feb 14, 2023
visionary wealth advisors
6.39%
1,030,135
SC 13G
Feb 10, 2023
dimensional fund advisors lp
6.3%
1,010,647
SC 13G/A
Feb 15, 2022
visionary wealth advisors
5.61%
901,535
SC 13G
Feb 08, 2022
dimensional fund advisors lp
6.7%
1,070,696
SC 13G/A
Feb 17, 2021
visionary wealth advisors
5.39%
860,235
SC 13G
Feb 16, 2021
dimensional fund advisors lp
6.9%
1,097,073
SC 13G/A
Nov 06, 2020
whitmore bradford t
3.3%
518,616
SC 13D/A
Feb 18, 2020
visionary wealth advisors
5.18%
215,042
SC 13G

Recent SEC filings of Ultralife Corp

View All Filings
Date Filed Form Type Document
May 07, 2024
EFFECT
EFFECT
May 02, 2024
S-3/A
S-3/A
Apr 26, 2024
10-K/A
Annual Report
Apr 25, 2024
8-K
Current Report
Apr 25, 2024
10-Q
Quarterly Report
Apr 19, 2024
4
Insider Trading
Mar 29, 2024
S-3
S-3
Mar 21, 2024
10-K
Annual Report
Mar 13, 2024
4
Insider Trading
Feb 15, 2024
8-K
Current Report

Peers (Alternatives to Ultralife Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
58.8B
23.0B
20.26% 50.77%
43.8
2.55
9.35% -48.07%
21.1B
5.5B
0.45% 39.98%
29.05
3.84
8.06% 32.52%
20.4B
17.1B
-6.83% 36.60%
13.91
1.19
-18.27% -40.02%
19.9B
4.9B
13.40% 94.52%
23.21
4.06
-3.54% 3.11%
12.9B
-
-4.07% 33.20%
23.62
3.13
6.67% 16.79%
MID-CAP
8.0B
3.9B
4.36% 61.38%
21.17
2.08
-6.35% -0.40%
6.2B
1.2B
-13.17% 22.84%
34.26
5.29
19.83% 50.95%
5.5B
3.4B
-10.63% 22.26%
8.95
1.64
-11.52% -24.82%
4.0B
1.6B
14.28% 14.49%
30.83
2.54
-16.80% -35.75%
2.4B
801.3M
18.68% -58.83%
-1.65
3
3.94% -88.36%
SMALL-CAP
1.5B
1.4B
18.99% 70.53%
14.78
1.04
-1.65% -4.32%
538.1M
141.5M
11.62% 34.84%
9.37
3.8
64.77% 235.59%
493.5M
1.8B
6.61% -0.96%
-20.23
0.28
-6.26% -71.83%
366.0M
103.0M
-19.00% -64.63%
-4
3.55
-24.12% 24.29%
56.3M
60.9M
-21.24% 23.91%
13.37
0.92
4.81% 82.22%

Ultralife Corp News

Latest updates
MarketBeat13 May 202408:53 pm
Defense World06 May 202406:51 am
Seeking Alpha22 Apr 202407:00 am

Ultralife Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-5.9%41,92744,54839,48842,69231,91636,10733,23432,12630,37323,76321,76126,77025,97328,97624,36228,56025,81431,02327,49329,39718,882
Cost Of Revenue-8.1%30,45733,14629,71432,10424,48028,02626,51924,48023,41518,47416,65319,50318,99521,62517,85120,59718,48021,66819,63220,53213,798
Gross Profit0.6%11,47011,4029,77410,5887,4368,0816,7157,6466,9585,2895,1087,2676,9787,3516,5117,9637,3349,3557,8618,8655,084
Operating Expenses-4.5%7,4077,7537,6396,9237,4107,8647,3016,8537,2536,5185,8876,1766,0266,1365,8045,6695,8496,8836,5555,8234,536
  S&GA Expenses-4.2%5,6515,9015,7705,1455,3786,2085,4055,1815,3964,9154,1644,3234,3794,6184,1984,3944,3014,7304,5264,2363,500
  R&D Expenses-5.2%1,7561,8521,8691,7782,0321,6561,8961,6721,8571,6031,7231,8531,6471,5181,6061,2751,5482,1532,0291,5871,036
EBITDA Margin21.1%0.11*0.09*0.06*0.05*0.03*0.03*0.02*0.01*0.02*0.03*0.07*0.08*0.09*--------
Income Taxes167.3%7032634461,375-133-155-90.00170-251-211-17524821768219249931951522567641.00
Earnings Before Taxes15.9%3,6073,1131,7494,723-468-380-332678-412-1,339-7781,0708962,7996542,1771,3932,1761,1462,959490
EBT Margin36.1%0.08*0.06*0.04*0.02*0.00*0.00*-0.01*-0.02*-0.01*0.00*0.04*0.05*0.06*--------
Net Income0.6%2,8912,8731,3303,340-346-224-239512-168-1,131-5858116712,1084071,6581,0591,6268982,256425
Net Income Margin36.4%0.06*0.05*0.03*0.02*0.00*0.00*-0.01*-0.01*-0.01*0.00*0.03*0.04*0.04*--------
Free Cashflow-131.7%-4531,427-1,4231,235-1,8622,281-1,238-392-3,593-4,6274082,3163,414--------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets1.3%181178176175171168168162161160137137136138136138146145143142121
  Current Assets4.5%94.0090.0090.0088.0081.0079.0079.0072.0069.0067.0065.0064.0064.0064.0062.0065.0074.0070.0069.0069.0065.00
    Cash Equivalents-1.7%10.0010.009.008.006.006.005.005.006.008.0016.0016.0014.0011.0014.008.006.007.007.007.0021.00
  Inventory3.8%44.0042.0047.0046.0047.0041.0041.0039.0036.0033.0028.0027.0028.0028.0030.0028.0029.0030.0032.0034.0028.00
  Net PPE-2.1%21.0021.0021.0021.0021.0022.0022.0022.0022.0023.0023.0023.0023.0023.0023.0023.0022.0023.0023.0022.0012.00
  Goodwill-0.2%37.0038.0037.0038.0038.0037.0037.0038.0038.0038.0027.0027.0027.0027.0027.0026.0026.0027.0026.0027.0020.00
Liabilities-2.4%52.0053.0054.0056.0055.0052.0053.0045.0044.0042.0018.0017.0019.0021.0022.0025.0036.0035.0036.0036.0017.00
  Current Liabilities-1.5%23.0024.0026.0029.0029.0029.0028.0022.0020.0019.0017.0016.0017.0019.0017.0014.0019.0017.0018.0020.0016.00
  Long Term Debt-2.0%23.0024.0024.0023.0021.0019.0021.0020.0020.0019.00----2.009.0015.0016.0016.0014.00-
    LT Debt, Current0%2.002.002.002.002.002.002.002.002.002.000.001.001.001.002.001.001.001.001.001.00-
    LT Debt, Non Current-2.0%23.0024.0024.0023.0021.0019.0021.0020.0020.0019.00----2.009.0015.0016.0016.0014.00-
Shareholder's Equity2.8%129125122120116116115117118118119119118117114112110110107106104
  Retained Earnings7.1%-37.86-40.75-43.63-44.96-48.30-47.95-47.73-47.49-48.00-47.83-46.70-46.12-46.93-47.60-49.71-50.11-51.77-52.83-54.46-55.35-57.61
  Additional Paid-In Capital0.4%190189189188188187187187187187186186186185185185185184184183183
Shares Outstanding0.6%16.0016.0016.0016.0016.0016.0016.0016.0016.0016.0016.0016.0016.00--------
Minority Interest13.7%0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.01-0.03-0.06
Float----47.00---44.00---83.00---69.00---78.00-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-103.3%-81.002,432-8891,751-1,3652,564-427-178-3,222-4,1371,5073,0523,90322912,6099,247-3651,877-601-3,701-545
  Share Based Compensation54.8%161104131154139224179184189159142186184187222304230377159175185
Cashflow From Investing63.0%-372-1,005-534-516-497-283-811-214-371-24,009-1,099-736-489-1,199-369-968-445-1,435-1,053-26,460-2,581
Cashflow From Financing161.5%185-3012,4291,5621,800-1,5791,303-4291,22320,578-394-122-420-2,436-6,909-6,027-322-3792,17715,935-1,609
  Buy Backs---------------------1,957
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

ULBI Income Statement

2024-03-31
Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues$ 41,927$ 31,916
Cost of products sold30,45724,480
Gross profit11,4707,436
Operating expenses:  
Research and development1,7562,032
Selling, general and administrative5,6515,378
Total operating expenses7,4077,410
Operating income4,06326
Interest and financing expense(520)(424)
Miscellaneous income (expense)64(70)
Total other expense(456)(494)
Income (loss) before income taxes3,607(468)
Income tax provision (benefit)703(133)
Net income (loss)2,904(335)
Net income attributable to non-controlling interest1311
Net income (loss) attributable to Ultralife Corporation2,891(346)
Other comprehensive loss:  
Foreign currency translation adjustments(232)197
Comprehensive income attributable to Ultralife Corporation$ 2,659$ (149)
Net income (loss) per share attributable to Ultralife common stockholders – basic (in dollars per share)$ 0.21$ 0.03
Net income (loss) per share attributable to Ultralife common stockholders – diluted (in dollars per share)$ 0.21$ 0.03
Weighted average shares outstanding – basic (in shares)16,39616,135
Potential common shares (in shares)1220
Weighted average shares outstanding - diluted (in shares)16,51816,135

ULBI Balance Sheet

2024-03-31
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash$ 10,099$ 10,278
Trade accounts receivable, net of allowance for expected credit losses of $300 and $300, respectively35,27831,761
Inventories, net43,82142,215
Prepaid expenses and other current assets5,1045,949
Total current assets94,30290,203
Property, plant and equipment, net20,67021,117
Goodwill37,49937,571
Other intangible assets, net14,86715,107
Deferred income taxes, net9,87310,567
Other noncurrent assets3,3403,711
Total assets180,551178,276
Current liabilities:  
Accounts payable13,31511,336
Current portion of long-term debt2,0002,000
Accrued compensation and related benefits2,0133,115
Accrued expenses and other current liabilities6,0487,279
Total current liabilities23,37623,730
Long-term debt23,14023,624
Deferred income taxes1,6751,714
Other noncurrent liabilities3,4153,781
Total liabilities51,60652,849
Commitments and Contingencies 
Stockholders’ equity:  
Preferred stock – par value $.10 per share; authorized 1,000,000 shares; none issued00
Common stock – par value $.10 per share; authorized 40,000,000 shares; issued – 20,887,446 shares at March 31, 2024 and 20,783,607 shares at December 31, 2023; outstanding – 16,451,332 shares at March 31, 2024 and 16,347,493 shares at December 31, 20232,0892,078
Capital in excess of par value189,995189,160
Accumulated deficit(37,863)(40,754)
Accumulated other comprehensive loss(3,892)(3,660)
Treasury stock - at cost; 4,436,114 shares at March 31, 2024 and 4,436,114 shares at December 31, 2023(21,492)(21,492)
Total Ultralife Corporation equity128,837125,332
Non-controlling interest10895
Total stockholders’ equity128,945125,427
Total liabilities and stockholders’ equity$ 180,551$ 178,276
ULBI
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables. The Communications Systems segment provides communications systems and accessories to support military communications systems, such as radio frequency amplifiers, power supplies and cables, connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, and integrated communication systems for fixed or vehicle applications comprising vehicle adapters, vehicle installed power enhanced rifleman appliqué systems, and SATCOM systems. This segment's military communications systems and accessories are designed to enhance and extend the operation of communications equipment, such as vehicle-mounted, manpack, and handheld transceivers. The company sells its products under the Ultralife Batteries, Lithium Power, McDowell Research, AMTITM, ABLETM, ACCUTRONICS, ACCUPRO, ENTELLION, SWE Southwest Electronic Energy Group, SWE DRILL-DATA, SWE SEASAFE, Excell Battery Group, and Criterion Gauge brands through original equipment manufacturers, and industrial and defense supply distributors. In addition, it sells its 9-volt battery to the broader consumer market through national and regional retail chains and online retailers. The company serves government, defense, and commercial sectors. Ultralife Corporation was incorporated in 1990 and is headquartered in Newark, New York.
 CEO
 WEBSITEultralifecorporation.com
 INDUSTRYCommunication Equipment
 EMPLOYEES547

Ultralife Corp Frequently Asked Questions


What is the ticker symbol for Ultralife Corp? What does ULBI stand for in stocks?

ULBI is the stock ticker symbol of Ultralife Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Ultralife Corp (ULBI)?

As of Fri May 17 2024, market cap of Ultralife Corp is 185.08 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ULBI stock?

You can check ULBI's fair value in chart for subscribers.

What is the fair value of ULBI stock?

You can check ULBI's fair value in chart for subscribers. The fair value of Ultralife Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Ultralife Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ULBI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Ultralife Corp a good stock to buy?

The fair value guage provides a quick view whether ULBI is over valued or under valued. Whether Ultralife Corp is cheap or expensive depends on the assumptions which impact Ultralife Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ULBI.

What is Ultralife Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, ULBI's PE ratio (Price to Earnings) is 17.74 and Price to Sales (PS) ratio is 1.1. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ULBI PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Ultralife Corp's stock?

In the past 10 years, Ultralife Corp has provided 0.109 (multiply by 100 for percentage) rate of return.